$361.09
-5.91-1.61%
Últ. Act.: Sep 29, 3:31 AM
BeOne Medicines Ltd
ONCNASDAQ
BeOne Medicines Earnings & Forecasts
BeOne Medicines (ONC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BeOne Medicines Guidance
BeOne Medicines (ONC) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $6.6B - $6.8B para el período.
En comparación con la previsión anterior, BeOne Medicines elevado redujo su previsión de ingresos desde un rango anterior de $6.3B - $6.5B.
BeOne Medicines ha emitido 7 actualizaciones de orientación entre el febrero 27, 2025 y el agosto 5, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.44 | $0.79 | $1.42 | $0.80 |
| Actual | $3.84 | $3.24 | $1.95 | $2.65 |
| Surprise | +166.7% | +310.1% | +37.3% | +231.3% |
| Revenue | ||||
| Estimate | $1.59B | $1.44B | $1.45B | $1.35B |
| Actual | $1.71B | $1.51B | $1.50B | $1.41B |
| Surprise | +7.19% | +5.00% | +3.10% | +4.26% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.94 | $1.65 | $2.96 | $3.31 |
| Revenue | ||||
| Consensus | $1.76B | $1.79B | — | — |